| INTRODUC TI ON
Two well-characterized antigens are absent in humans but present in mammals and include galactose-α1, and N-glycolylneuraminic acid (Neu5Gc) whose synthesis are catalysed by α(1,3) galactosyltransferase (encoded by the GGTA1 gene)
1,2 and CMP-Neu5Gc hydroxylase (encoded by the CMAH gene) [3] [4] [5] respectively. These have been identified as major antigens in xenotransplantation studies or retrospective clinical findings 3 . Pigs that carry mutations in both genes, and therefore lack these xenoantigens, have been generated. 6 Moreover, porcine kidneys lacking αGal are not hyperacutely rejected. 7 It is also expected that such tissues will be less immunogenic for patients being implanted with animal-derived tissues engineered to lack both antigens.
One of the major clinical applications of xenogenic tissues is for the manufacturing of bioprosthetic heart valves (BHVs), and it has been shown that such tissues carry the same xenoantigens despite the glutaraldehyde treatments used in the manufacturing process 8, 9 .
Almost 300 000 patients are now undergoing BHV replacement each year 10 with a growing demand. The sources of BHV are those manufactured from pig or bovine pericardia as compared to mechanical heart valve (MHV) that require lifelong anticoagulation therapy.
Bovine BHVs suffer however premature structural valve degeneration (SVD). The functionality of BHV is maintained for 10-15 years in older patients. However, in younger (<35 years old) patients, BHVs undergo SVD much earlier. 11 It is hypothesized that among various metabolic causes, SVD is also immune-mediated since both αGal 8, 12 and Neu5Gc 9, 13 are still present on the BHV used in the clinic.
After BHV replacement, there is an increase of anti-αGal antibodies 14, 15 and it has been reported in an experimental context that implantation of BHV from αGal-knockout pigs into primates is associated with a reduced anti-αGal immune response. 16 Moreover, valves from αGal/Neu5Gc-deficient pigs further reduce human IgM/ IgG binding when compared to BHV from wild-type pigs 17 . A similar situation is likely to occur whether bovine double knockout (DKO)
tissue would be used. Seventy per cent of the BHV currently used in the clinic are in fact manufactured with bovine pericardia, that carries non-negligible amounts of αGal 8 and of Neu5Gc 9 even after currently used manufacturing treatments.
Pig-and cattle-derived products are also a major source of proteins for human consumption, and particularly, cattle are the major source of dairy products. Such products can become allergenic for some patients or infants consuming baby milk replacers. This allergy, known as the red meat allergy syndrome, 18, 19 generally follows a tick bite inducing an isotype shift for IgE against αGal antigen. Neu5Gc
is not synthesized by humans, but it can be incorporated through the diet and found in minute amounts in endothelial or epithelial cells of various tissues, likely contributing to inflammation-related diseases. 20, 21 Furthermore, cattle can be used as a "bioreactor" to produce bioactive molecules for nutraceuticals or biomedical use, including r-human lactoferrin 22 in bovine milk. However, the resulting product differs from the human one because of the different glycosylation pattern. 23 Similarly, partially "humanized" antibodies 24 produced in cattle for various purposes still display Neu5Gc epitopes 25, 26 that might be the target of an immune response by the host with clinically relevant side effects.
The scope of the present work was to generate cattle KO for both αGal and Neu5Gc antigens using a genome editing approach.
27
A stillborn calf KO for αGal has been reported, 28 but to the best of our knowledge, this work has not progressed further. Availability of DKO cattle line offers the opportunity to explore the potential of such animals to provide low immunogenic cattle-derived products for clinical purposes as well as for the food industry and human consumption. Bovine adult fibroblasts (BAFs) were derived from a skin biopsy of a Holstein bull and a cow with previous successful record of somatic cell nuclear transfer (SCNT). Recipient heifers used as surrogate mothers were also of Holstein breed.
| MATERIAL S AND ME THODS

| Animal experiments and source of animals
| Chemicals
All chemicals were purchased from Sigma-Aldrich (Milano, Italy) unless otherwise stated.
| PCR set-up for identification and validation of target genes
Ensemble database was analysed to obtain the Reference genome sequences for the GGTA1 (ENSBTAG00000012090) and of the CMAH (ENSBTAG00000003892) genes. These sequences were studied in silico to identify possible target sequences, and the selected regions were amplified by PCR and analysed with Sanger sequencing to exclude polymorphisms in male and female fibroblast cell lines selected for the genome editing.
Editing of GGTA1 gene started initially in the male line targeting the exon 9 and because of the paucity of tools available at the time we never found efficient RNA guide. Therefore, we decided to use two guides that targeted the same sequence ( 
| Genomic DNA extraction and PCR conditions
Primary fibroblasts and tissues biopsies were lysed at 55°C for All the amplifications were performed using Takara La Taq DNA Polymerase (Takara, Japan).
Polymerase chain reaction conditions for GGTA1 in the male line Determination of the absence of any genomic polymorphisms was achieved cloning each resulting PCR products in E coli using the TOPO TA cloning kit (Thermo Fisher Scientific). Resulting purified plasmids (Plasmid Mini kit, Qiagen) were subjected to Sanger sequencing analyses (Eurofins Genomics).
| CRISPR/Cas9 plasmid constructs, single guide RNA synthesis and design of ssCMAH-STOP oligonucleotide
Editing of the GGTA1 and CMAH genes of the bovine male line was achieved by cloning and expressing the desired single guide RNAs Edited female colonies were obtained transfecting the Cas9 protein/gRNA ribonucleoprotein complexes (Cas9-RNPs). 31, 32 Desired sgRNAs (btGGTA1cr3 and btCMAHcr2) were in vitro synthetized following the CRISPOR guidelines (http://crisp or.org/).
Briefly, oligonucleotides (Table 3) 
| Culture, transfection and selection of adult fibroblasts
Bovine adult fibroblasts (male and female) were cultured in DMEM + M199 (1:1) +10%FCS in 5%CO 2 , 5%O 2 at 38°C. TA B L E 3 Oligonucleotides used for in vitro T7 transcription of sgRNAs used for the female line with the btGGTA1cr3-sgRNA (3.6 μg), the btCMAHcr2-sgRNA (3.6 μg) and 0.4 nmol of the ssCMAH-STOP oligo.
Transfected cells were plated in a 60-mm dish and cultured for 3 days when they were passaged 1-3. Day 7 male (6.5 × 10 6 cells) and D5 female (2.3 × 10 6 cells) αGal-negative cells were selected using F I G U R E 1 Editing of GGTA1 and CMAH genes in male and female fibroblasts. A, Target sequences for selected sgRNAs and ssCMAH-STOP oligo sequence. For each bovine gene (GGTA1 and CMAH), target sequences are indicated on the respective exons recognized by the selected sgRNAs. PAM sequences are highlighted in blue. In the ssCMAH-STOP oligo sequence, the TAA (STOP) codon is highlighted in bold character; the AflII restriction site is underlined. B, PCR analyses of female colonies. The results of the PCR analyses performed for the genomic characterization of the female colonies (A1, A2, A3, A4, A5 and A6) selected after Dynabeads sorting are reported as an example. Each colony was analysed for the GGTA1 gene (739 bp) and for the CMAH gene (225 bp). Resulting electrophoretic patterns determined directly that some colonies were characterized by visible Indels, creating bands different from the WT controls. This situation is clear for colonies A1 (double band), A2 (deletion) and A6 (deletion) in PCR analyses for the GGTA1 gene (°) and for colonies A1 (double band) and A5 (deletion) in PCR analyses for the CMAH gene (#). Resulting CMAH-PCR products were also digested with the AflII restriction enzyme, detecting the alleles interested by the targeting event. Due to the introduction of a STOP codon (TAA) in the START position (ATG) of the CMAH gene, only the HDR-CMAH alleles will be cut by the restriction enzyme producing two lower bands (152 + 73 bp). A simple agarose electrophoresis enabled us to identify possible additional edited colonies detecting the STOP codon insertion (**) for colonies A2 and A6 and the single insertion (*) for colonies A3 and A4. In these last ones, the not targeted allele resulted uncut (225 bp) as the WT sample. For this reason, the final determination of the exact Indels, occurred in all the edited colonies, was determined by Sanger sequencing of the resulting TOPO TA E coli clones. 100 = 100 bp ladder (Thermo Fisher Scientific); A1, A2, A3, A4, A5 and A6 = transfected females colonies; WT = wild-type female line; H 2 0 = Nucleases-free water. C, Sequences alignments of colonies used for the SCNT. Sanger sequencing outlining the mutations affecting the GGTA1 and the CMAH genes of colonies selected for the SCNT step. For the GGTA1 gene, the exon 9 was used as reference for the male colonies and a PCR product including the exon 4 was used for the female ones. In both cases, deletions of different lengths were obtained (Table S1 ). For the CMAH gene, all edited alleles of the edited colonies were aligned using as reference a PCR product including the exon 2 sequence. In this case, in both lines, we were able to determine the TAA substitution, as result of the targeting event mediated by the site-specific cut, produced by the CRISPR/Cas9 system driven by the sgRNA btCMAHcr1
(A) (C) Eight (four male and four female) confirmed DKO colonies, edited for GGTA1 and CMAH genes, were selected for further screening in SCNT to assess developmental potential. Before SCNT embryos were transferred into recipients, at least 10 cloned embryos of each selected colony were analysed for the absence of wild-type genotypes. Genomic DNA extraction procedure, PCR amplification and sequencing reactions were done using the same materials and methods described above.
| Somatic cell nuclear transfer (SCNT)
The protocol used is described in Galli et al 36 with minor modifications. Briefly, the bovine ovaries were collected at a local abattoir. 
| Recipients synchronization, embryo transfer (ET) and calving
Heifers of 14-16 months of age were used as recipients. Oestrus was synchronized using the Ovsynch protocol with two injections of a GnRH analogue (Dalmarelin, Fatro, Italy) 8 days apart. Forty-eight hours after the second injection, animals were observed for oestrus signs and 6 days later those that showed oestrus were ultrasound scanned to detect the presence of a corpus luteum (CL). Those that had a well-developed CL received 1 or 2 embryos (either fresh or frozen thawed) by non-surgical ET ipsilateral to the CL. Four weeks after ET, pregnancy diagnosis was performed by ultrasound scanning and then the pregnant animals were checked at monthly interval till the end of the pregnancy. The delivery of the calves was by elective caesarean section at 280 days of gestation.
| Genotyping and phenotyping analyses for αGal and Neu5Gc antigens in DKO cattle-derived primary cells
Newborn calves were subjected to ear biopsy to establish a primary cell line, to extract the genomic DNA for genotyping by PCR and Editing of the female fibroblasts took place a year later, and we used a different system using neon transfection with the Cas9 protein for the first time. From the one million female fibroblasts transfected with Neon and the Cas9-RNP at D5, 2.3 × 10 6 cells were used for Dynabeads sorting. The efficiency of transfection was very low compare to the editing of male fibroblasts that was obtained using a plasmid for transfection but all αGal-negative cells were plated in one 150-mm dish and after 9 days 6 colonies were picked up. Of the 41 male colonies selected by pick up and analysed, CMAH-PCR
and AflII-RFLP analyses revealed that 15 appeared to be edited for the CMAH gene and for this reason they were sent for Sanger sequencing analyses of their GGTA1 and CMAH genes ( Figure 1C and Table S1 ). GGTA1-KO was confirmed in all 15 colonies and 13 (31.7%) resulted also KO for Neu5Gc ( Table 4 ).
The female colonies were subjected to the same analysis. The PCR analysis ( Figure 1B ) followed by Sanger sequencing analyses ( Figure 1C and Table S1 ) on both genes of the six female colonies revealed that two colonies were heterozygotes and four colonies were KO (66.6%) for the CMAH gene and that all six colonies were F I G U R E 2 DKO calves and sequencing results. A, Pictures of cloned DKO calves. Two healthy cloned bull calves (9161 and 9162) were generated from two different DKO colonies (A4 and E3). Cloned heifer calf was generated using the colony A6. B, Sequencing results for 9161. For the GGTA1 gene, it was confirmed that this gene is affected by two different deletions (21 and 171 bp), as previously described for the edited colony A4 (Table S1) . These data were finally demonstrated by the deletion (17 bp) generated in the CMAH gene. C, Sequencing results for 9162. The GGTA1 gene sequence presented a 8 bp deletion, and the CMAH gene is characterized by the same 2 different mutations (TAA substitution; del 13 bp) detected in colony E3 (Table S1 ). D, Sequencing results for 9163. The same Indels, characterizing the GGTA1 (del 54 bp) and the CMAH (TAA substitution) genes of A6 colony (Table S1) , were confirmed
(A) (B) (D) (C) (A) (B)
F I G U R E 3 FACS analyses for 9161, 9162 male calves. Fibroblasts from wild-type animal (WT) and from the edited male calves were analysed by FACS. As negative controls, pig DKO fibroblasts were used as no bovine material was available. The results demonstrated that the αGal (A) and (B) Neu5Gc antigens were absent from the cell surface of cloned calves, confirming the genotype analyses for the knocked-out genes (GGTA1 and CMAH). Fibroblasts WT (positive control): wild-type primary fibroblasts from the bovine line prior to genetic modification expressing the αGal and the Neu5Gc antigens. Pig fibroblasts Gal-KO and Neu5Gc-KO (negative control): porcine primary fibroblasts NOT expressing the αGal and the Neu5Gc antigens. Fibroblasts 9161/9162 Gal-KO and Neu5Gc-KO: primary fibroblasts derived from cloned DKO calves (Table 4) , confirming the high efficiency of Dynabeads selection for the GGTA1 KO.
GGTA1-KO
Male A4 and E3 and female A6 colonies were used for SCNT based on their morphology and growing characteristics and embryo production after SCNT. Ten SCNT embryos of each colony were sequenced to confirm the purity of the selected colonies for the required mutations ( Figure 1C ) to avoid potential contaminations of WT cells.
| Generation of DKO calves by SCNT
Two male DKO colonies (A4 and E3) were used as nuclear donors for SCNT (Table 5 ). Seven blastocysts (BLs), derived from colony A4, were transferred in 5 synchronized recipients, 4 (80%) became pregnant and 1 pregnancy (25%) went to term delivering 1 calf (9161, Figure 2A ). Fifteen BLs derived from colony E3 were transferred in 12 synchronized recipients; 5 (41.6%) became pregnant, 1 pregnancy (20%) went to term delivering 1 calf (9162, Figure 2A ).
Female DKO colony A6 was used for SCNT, and 31 BLs were transferred in 16 recipients; 6 (37.5%) became pregnant and 1 pregnancy went to term delivering 1 calf (9163, Figure 2A ).
| Genotyping of cloned calves
Sanger sequencing of TOPO TA-cloned PCR products of DKO calves confirmed the Indels characterizing the colonies used for cloning. In details, in clone 9161, GGTA1 gene is affected by two different mutations in exon 9 (del AGACCCTGGGCGAGTCGGTGG/ del 171bp) and the exon 2 of the CMAH gene carries a deletion (del GGCAGGCAAGTGAGGGA) as it was described for colony A4 (Table S1 ; Figure 2B ). In clone 9162 (Figure 2A ), a deletion in GGTA1 gene (del AGTCGGTG) is accompanied by 2 different mutations in the exon 2 of CMAH gene. The first allele was inactivated by the substitution of the ATG codon (START) with the TAA codon (STOP), due to the homology-directed repair (HDR) event driven by the ssCMAH-STOP oligo, as described for colony E3 (Table S1 , Figure 2C ), and the second allele has 13 bp deletion (del AGGCAAGTGAGGG).
Sanger sequencing results of female clone 9163 (Figure 2A) demonstrated that a deletion in the exon 4 of the GGTA1 gene (del 54bp) and the substitution of the START to a STOP codon (ATG TAA) in the exon 2 of the CMAH gene are identical to the Indels described for the donor female colony A6 (Table S1, Figure 2D ). PCR analyses on the male calves (data not shown) demonstrated also that the CRISPR/Cas9 expression vectors were not integrated in the genome of the cloned calves.
| Phenotyping of cloned calves
FACS analysis confirmed the genotyping results of the three calves.
All primary cell lines derived from biopsies of the cloned male calves do not express αGal ( Figure 3A ) and Neu5Gc ( Figure 3B ) as opposed to WT control cells before genetic engineering. As negative controls, pig cells KO for both antigens were used. The female phenotyping was performed in the same way as for the males but in this case the negative control was the male 9162. In this experiment performed a year later with different experimental context, the αGal was completely negative. In the case of Neu5Gc, both the control (9162) and the female (9163) had some background staining. Since the 9162 pictured in Figure 3 is the same as in Figure 4 , we can conclude that the tail of Neu5Gc staining is background staining coming from the different experimental setting and culture conditions.
| D ISCUSS I ON
In this work, we targeted two well-known xenoantigens identified as such from pig xenotransplantation studies that are also expressed in cattle. Here, we show that editing bovine fibroblasts are possible using both CRISPR/Cas9 in plasmid and Cas9-RNP formats and live animals can be generated through SCNT. The advent of programmable nucleases for genome editing in large animals, especially the pig, has greatly increased its efficiency by reducing the number of animals required and the costs involved. The number of genetically modified pigs and the consequent generation of animal models through precise genetic engineering have grown exponentially in the last 10 years. However, genetically modified cattle are still very few due to some constrains for applying this technology to this species such as the long generation interval. Nevertheless, cattle would be more relevant for food production since it is a major source of beef and dairy products. Furthermore, one of the major potential applications for DKO cattle for both GGTA1 and CMAH would be as a source of less immunogenic biological materials (pericadia) to manufacture BHV. In addition, genetically engineered cattle would also allow to produce food to avoid, for example, anaphylactic reaction following the consumption of red meat in some allergic individuals.
Despite the low transfection efficiency in bovine fibroblasts that affected the total number of edited colonies, because of the thorough screening of the few colonies selected and the combination with SCNT, we were able to generate DKO male and female calves.
All the bovine genome editing work was undertaken to disrupt simultaneously the GGTA1 and the CMAH genes without the need of a selectable marker, choosing primary cell lines whose genomic sequences were not affected by polymorphisms. We started the bovine genome editing work in the male line transfecting the plasmid format of the S pyogenes CRISPR/Cas9 system, while later its Cas9-RNP format was tested in the female line.
We selected to target exon 9 of GGTA1 gene in the male line using together two different sgRNAs (btGGTA1cr1 and btGGTA1cr2- Figure 1A) . In contrast to the female line, we targeted the exon 4, using the protein (Cas9-RNP), designing a sgRNA specific for the START codon (btGGTA1cr3 Figure 1A) . The use of Dynabeads and IB4 lectins greatly compensated for the low transfection efficiency very effectively since all the analysed colonies derived from cells that did not bind IB4 were all KO for the GGTA1 F I G U R E 4 FACS analyses for DKO female 9163 calf. Fibroblasts from wild-type animal (WT) and from the edited female calf were analysed by FACS. As negative controls, FACS-validated DKO fibroblasts from 9162 male calf were used. The results demonstrated that the αGal (A) and (B) Neu5Gc antigens were absent from the cell surface of cloned female calf, confirming the genotype analyses for the knocked-out genes (GGTA1 and CMAH). Fibroblasts WT (positive control): wild-type primary fibroblasts from the bovine line prior to genetic modification expressing the αGal and the Neu5Gc antigens. Fibroblasts 9162 Gal-KO and Neu5Gc-KO (negative control): bovine primary fibroblasts NOT expressing the αGal and the Neu5Gc antigens. Fibroblasts 9163 Gal-KO and Neu5Gc-KO: primary fibroblasts derived from cloned DKO female calf (A) (B) ( Table 4) . As a consequence, also the KO rate for the CMAH gene was very high indicating that when these nucleases enter the cells, they are very effective on all the targets. This event was also described for the pig by Li et al. 38 The use of ssODN-mediated KI with CRISPR/Cas9 system for KO purposes was also possible in cattle and facilitated the PCR screening because of the insertion of an AflII restriction site. The use of the plasmid to introduce and express all the machinery required was in our experiments more efficient than the use of the protein but because we required only a few cell clones for SCNT, it did not affect the success at the end since we had far more cell clone that we could need for SCNT. The 
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